Wednesday, April 12, 2017 10:39:40 PM
NEW YORK, NY -- (Marketwired) -- 04/06/17 -- DOLAT VENTURES, INC. (OTC PINK: DOLV) announces recent corporate developments.
The control of the Company was acquired by Mr. DeQun Wang on January 11, 2017 pursuant to an agreement that was entered into on December 2, 2016. On that date Mr. Wang acquired 300,000 shares of the Company's Class C Preferred Stock which is convertible into 750,000,000 shares of the Company's common stock and carries an equal number of votes.
Incorporation authorizing the preferred stock, the Company also acquired all of the issued and outstanding shares of Ji Ming Yang Amperex Technology Limited (Ji Ming Yang), a Chinese corporation in exchange for one hundred thousand Class D Preferred Stock convertible into 100,000,000 shares of the Company's common stock. Subject to FINRA approval the Company will reflect the new business combination by changing its name to JB&ZJMY Holding Company, Inc. and seeking a new symbol.
About Ji Ming Yang Amperex Technology Limited
Founded in March of 2015, http://zhongjimingyang.com/en Ji Ming Yang focuses on the development of batteries for "New Energy Vehicles". The company possesses a number of patents seeking to enhance and extend battery life while also reduce operating costs. The Company seeks to commercialize solutions to the problems faced by all vehicle battery manufactures, such as shortage of battery life, expensive materials, and charging station issues.
As part of the acquisition the company will be offering to current and future employees based in the Peoples Republic of China the opportunity to purchase new JB&ZJMY common stock units for $0.10 (Ten Cents USD) per share with one warrant attached exercisable for two years at $0.15 (Fifteen Cents USD) for a total of 10,000,000 (Ten Million) units pursuant to a Regulation S offering on a best efforts basis expiring on July 17th 2017.
The Company intends to file consolidated financial statements reflecting the acquisition during the next two weeks. We thank our shareholders for their interest in the Company and patience while we bring our filings current.
All of my posts are my opinion only and are not meant to be investment advice.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM